Kesiktas, Fatma Nur, et al
Access the full publication through NEJM.org for detailed methodology, adverse event data, and subgroup analyses
Metformin versus Ozempic Ozempic, a form of semaglutide, is a once-weekly subcutaneous injection, typically injected in the upper arm, thigh, and stomach on a rotating schedule
By leveraging its dual hormonal action, appetite-suppressing properties, metabolic enhancements, and robust clinical efficacy, Tirzepatide offers a valuable option for individuals struggling with obesity and related metabolic conditions
It emphasizes early diagnosis and treatment, he notes, changing the landscape for managing metabolic diseasesfor example, by sharply curtailing patient progression to diabetes with GLP-1 medications
They can provide personalized advice, recommend an appropriate treatment plan, and monitor your progress to ensure the best possible results